VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol

<b>Background/Objective:</b> The vascular endothelial growth factor (VEGF) signaling pathway induces angiogenesis, which impacts tumor progression and clinical outcomes in patients with localized osteosarcoma. This study evaluates whether genetic polymorphisms in the VEGF signaling pathway are assoc...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Juliana Salazar, María J. Arranz, Javier Martin-Broto, Massimo Serra, Emanuela Palmerini, Jeronimo Martínez-García, Antonio Juan-Ribelles, Maitane Andion, Javier Martinez-Trufero, Guiomar Gutiérrez, Aizpea Echebarria-Barona, Maria A. Vaz-Salgado, Alexandra Regueiro, Rosa Alvarez, Claudia Valverde, Pablo Luna, Pilar Blay, Ana Sebio
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2025-12-01
Sarja:	Pharmaceuticals
Aiheet:	pharmacogenetics osteosarcoma VEGF polymorphism
Linkit:	https://www.mdpi.com/1424-8247/18/12/1855
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!